Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lawrence Wruble"'
Autor:
N. Ettinger, Bing Zhang, Alan Safdi, Martin Rose, Robyn G Karlstadt, Michael P. DeMicco, Douglas Dalke, Jeffrey Medoff, Lawrence Wruble, Jeffrey Bernstein
Publikováno v:
Gastrointestinal Endoscopy. 65:660-670
Background The bowel purgative Visicol contains microcrystalline cellulose (MCC) residue, which may impair full visibility during a colonoscopy. An MCC residue-free sodium phosphate (RF-NaP; OsmoPrep) tablet was developed. Objective To investigate ap
Autor:
Ronald Pruitt, David Sales, George Koval, John K Bell, Dennis Riff, Lawrence Wruble, Lorin K Johnson, Douglas S. Levine
Publikováno v:
The American Journal of Gastroenterology. 97:1398-1407
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis
Autor:
Richard Chasen, Eric Weiss, Cuckoo Choudhary, David Kastenberg, Stephen E. Steinberg, Lawrence Wruble, Dennis Riff
Publikováno v:
Gastrointestinal Endoscopy. 54:705-713
Background: Liquid purgatives for cleansing before colonoscopy often are poorly tolerated. A sodium phosphate tablet has been developed to provide equivalent efficacy with better patient tolerance. These 2 studies compare the safety, efficacy, and pa
Autor:
Michael Safdi, John S. Hanson, Pamela Doty, Lorin K. Johnson, George Koval, John Johanson, Amanda Cross, Ronald Pruitt, Robert Hardi, Barry Winston, Lawrence Wruble, Dennis Riff
Publikováno v:
The American journal of gastroenterology. 97(12)
Balsalazide is a novel azo-bonded 5-aminosalicylic acid treatment for mild-to-moderate ulcerative colitis. The study objective was to compare symptomatic remission rates with balsalazide and mesalamine while controlling for extent of disease and time
Autor:
Douglas S, Levine, Dennis S, Riff, Ronald, Pruitt, Lawrence, Wruble, George, Koval, David, Sales, John K, Bell, Lorin K, Johnson
Publikováno v:
The American journal of gastroenterology. 97(6)
Balsalazide is a new innovative, mesalamine-containing prodrug that is activated by bacteria in the colon. Balsalazide has been shown previously to be well tolerated and effective in the treatment of acute ulcerative colitis. The aim of this study wa
Autor:
Amanda J. Cross, John F. Johanson, John S. Hanson, Dennis Riff, Pamela Doty, Ronald E. Pruitt, Lawrence Wruble, Michael Safdi, George Koval, Robert Hardi, Lorin K. Johnson, Barry Winston
Publikováno v:
Gastroenterology. 118:A120-A121
Autor:
Roland D. Shepard, Audrey L. Shaw, Lawrence Wruble, Alana A. Rosen, Shahriar Sedghi, William P. Forbes, Shirley Huang, Ron E. Pruitt, Shadreck M. Mareya
Publikováno v:
Gastroenterology. 136:A-523
Autor:
Alan A. Rosen, William P. Forbes, Ronald E. Pruitt, Shahriar Sedghi, Audrey L. Shaw, Shirley Huang, Shadreck M. Mareya, Roland D. Shepard, Lawrence Wruble
Publikováno v:
Gastroenterology. 134:A-494
Autor:
Jan Björk, Carol A. Burke, Sapna Syngal, Rosalind U. van Stolk, Martin Luchtefeld, Scott K. Kuwada, Rolf Hultcrantz, Miguel Rodriquez, V. Alin Botomon, Lawrence Wruble, Madir Arber
Publikováno v:
Gastroenterology. 118:A657